Researchers in the fields of obstetrics, gynecology, and Chinese integrative medicine (CIM) were invited to share their perspectives on the most recent studies.
In vitro fertilization (IVF) is a choice for more than 1 000 000 infertile couples each year, and is linked to over 3 000 000 babies born worldwide (Horsey, 2006) . In Europe, over 300 000 treatment cycles of IVF or intracytoplasmic sperm injections (ICSI) are performed each year (Andersen et al., 2007) , and in the United States, the children conceived through IVF or ICSI comprise 2%-3% of total births (Nygren and Andersen, 2001) . Various traditional medical practices originating in China have been widely used worldwide by women to improve health outcomes. CIM has been used to prevent miscarriage during the early phase of pregnancy, regulate the menstrual cycle, and alleviate menopausal symptoms. In recent years, many infertile couples have chosen CIM as an adjunct when they undergo IVF (Qu et al., 2012; Cao et al., 2013) . However, as the conclusions from the clinical trials have been inconsistent, clinical practitioners and infertile couples find it difficult to make a final decision on whether to choose CIM to improve IVF outcomes (Myers, 2006) . As well as with IVF, CIM is believed to improve outcomes when used in relation to unexplained infertility, early ovarian failure, polycystic ovary syndrome (PCOS), and amenorrhoea (Qu et al., 2012; Wu et al., 2016) . Additionally it is used if the menstrual cycle is prolonged due to an ovarian problem or where the patient wants to conceive quickly, such as with advancing age (35 years Human cervical cancer is the third most common cancer in women worldwide (Jemal et al., 2011) . Oncogenic human papillomavirus (HPV) infection is a prerequisite for the development of cervical cancer and its precursor lesions (Clifford et al., 2003) . More than 150 serotypes of HPV have been identified to date, of which about 40 types can infect the cervix. These HPV types are divided into high-risk and low-risk groups (Schiffman et al., 2011) . Persistent high-risk HPV (HR-HPV) infection is a major cause of cervical cancer. The introduction of cytological screening has remarkably reduced the incidence and mortality of cervical cancer and the cytology test has been a most widely accepted triage for patients with a positive primary HPV test (Zappacosta et al., 2013) . However, many developing countries, including China, lack well-trained cytologists, and therefore the cytology test cannot be carried out effectively. Therefore, other triage options should be considered in these countries. HPV testing has been recommended as a primary screening for cervical cancer in many countries (Zappacosta et al., 2013) .
More than 90% of women will experience HPV infection in their lifetime. A productive HR-HPV infection may develop into low-grade cervical lesions (low-grade squamous intraepithelial lesion/cervical intraepithelial neoplasia grade 1 (LSIL/CIN1)). HPV testing alone may increase the psychological burden and may cause over-referral to colposcopy. It has been reported that HPV E6/E7 mRNA expression level is highly correlated with the severity of cervical lesions (Ho et al., 2010) . HPV E6/E7 mRNA may be useful as a marker for potentially progressive HR-HPV infections and may constitute a useful tool for screening and/or patient management. In this issue, two studies by Yao et al. (2017) and Ye et al. (2017) , respectively, focus on some new research.
As we know, it has been widely recognized that maternal pre-pregnancy body mass index (pre-BMI) and gestational weight gain are closely associated with pregnancy outcomes including neonatal birth weight (NBW) (Stamnes Koepp et al., 2012; Li et al., 2014) . In 2009, the Institute of Medicine (IOM) of America introduced a guideline concerning appropriate maternal weight gain during different trimesters for singleton pregnancy, which may result in a better pregnancy outcome (Oken et al., 2009) . However, there has been no consensus about the suitability of this guideline for Chinese women and the reported appropriate gestational weight gain differs (Liu et al., 2012) . In this issue, Du et al. (2017) retrospectively analyzed the influence of maternal pre-BMI and weight gain in each trimester on NBW, hoping to properly guide maternal weight gain based on pre-BMI for Chinese pregnant women.
Overview
CIM has significant advantages in treating gynecological and obstetrics disorders. As early as in 1237 A.D., the first book devoted solely to gynecology and obstetrics of Chinese medicine, The Complete Book of Effective Prescriptions for Diseases of Women, was published. However, more large-size, randomized and multicenter trials should be conducted to improve the evidence base for the use of CIM for treating women's disorder.
